stockportfolio.pro
Core Laboratories Inc. P/E Ratio 2021–2025
Core Laboratories Inc. (CLB) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth -16.6%/yr over 4 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 25.41 | -2.7% |
| FY 2024 | 26.11 | +14.6% |
| FY 2023 | 22.78 | -52.4% |
| FY 2022 | 47.86 | -9.0% |
| FY 2021 | 52.58 | — |
Source: Core Laboratories Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for Core Laboratories Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCore Laboratories Inc. — frequently asked questions
What is Core Laboratories Inc.'s price-to-earnings ratio?
Core Laboratories Inc. (CLB) reported price-to-earnings ratio of 25.41 for fiscal year 2025, per its SEC filings.
How has Core Laboratories Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2021 and 2025, CLB's price-to-earnings ratio declined at roughly 16.6% per year (compound annual rate), from 52.58 to 25.41.
Where does this data come from?
Figures are computed from Core Laboratories Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.